Cargando…

Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion

Metformin hydrochloride (MET) sustained-release solid dispersions (SD) were prepared by the solvent evaporation and closed melt method, using compritol 888 ATO as the polymer with five different drug-carrier ratios. Characterization of solid dispersion was carried out by Fourier Transform Infrared (...

Descripción completa

Detalles Bibliográficos
Autores principales: Jagdale, SC, Patil, SA, Kuchekar, BS, Chabukswar, AR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159272/
https://www.ncbi.nlm.nih.gov/pubmed/21897658
http://dx.doi.org/10.4103/0975-1483.83758
_version_ 1782210439420051456
author Jagdale, SC
Patil, SA
Kuchekar, BS
Chabukswar, AR
author_facet Jagdale, SC
Patil, SA
Kuchekar, BS
Chabukswar, AR
author_sort Jagdale, SC
collection PubMed
description Metformin hydrochloride (MET) sustained-release solid dispersions (SD) were prepared by the solvent evaporation and closed melt method, using compritol 888 ATO as the polymer with five different drug-carrier ratios. Characterization of solid dispersion was carried out by Fourier Transform Infrared (FTIR) spectroscopy, ultraviolet (UV) spectroscopy, Differential scanning calorimetry (DSC), X-ray powder diffraction (XRPD). The FTIR and UV studies suggested that no bond formation had occurred between the polymer and the drug. DSC and XPRD results ruled out any interaction or complex formation between the drug and the polymer. The formulated SD had acceptable physicochemical characters and SD with a 1 : 4 drug : Polymer ratio, which released the drug over an extended period of eight-to-ten hours. The data obtained from the in vitro release studies were fitted with various kinetic models and were found to follow the Korsmeyer-Peppas equation. The prepared SD showed good stability over the studied time period. The solvent evaporation method was found to be more helpful than the closed melt method, giving the sustained release action. The SD with a 1 : 4 ratio of drug to polymer, by the solvent evaporation method, was selected as the most effective candidate for the subsequent development of a well-timed, sustained-release dosage form of the drug.
format Online
Article
Text
id pubmed-3159272
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-31592722011-09-06 Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion Jagdale, SC Patil, SA Kuchekar, BS Chabukswar, AR J Young Pharm Pharmaceutics Metformin hydrochloride (MET) sustained-release solid dispersions (SD) were prepared by the solvent evaporation and closed melt method, using compritol 888 ATO as the polymer with five different drug-carrier ratios. Characterization of solid dispersion was carried out by Fourier Transform Infrared (FTIR) spectroscopy, ultraviolet (UV) spectroscopy, Differential scanning calorimetry (DSC), X-ray powder diffraction (XRPD). The FTIR and UV studies suggested that no bond formation had occurred between the polymer and the drug. DSC and XPRD results ruled out any interaction or complex formation between the drug and the polymer. The formulated SD had acceptable physicochemical characters and SD with a 1 : 4 drug : Polymer ratio, which released the drug over an extended period of eight-to-ten hours. The data obtained from the in vitro release studies were fitted with various kinetic models and were found to follow the Korsmeyer-Peppas equation. The prepared SD showed good stability over the studied time period. The solvent evaporation method was found to be more helpful than the closed melt method, giving the sustained release action. The SD with a 1 : 4 ratio of drug to polymer, by the solvent evaporation method, was selected as the most effective candidate for the subsequent development of a well-timed, sustained-release dosage form of the drug. Medknow Publications 2011 /pmc/articles/PMC3159272/ /pubmed/21897658 http://dx.doi.org/10.4103/0975-1483.83758 Text en © Journal of Young Pharmacists http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Pharmaceutics
Jagdale, SC
Patil, SA
Kuchekar, BS
Chabukswar, AR
Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion
title Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion
title_full Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion
title_fullStr Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion
title_full_unstemmed Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion
title_short Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion
title_sort preparation and characterization of metformin hydrochloride — compritol 888 ato solid dispersion
topic Pharmaceutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159272/
https://www.ncbi.nlm.nih.gov/pubmed/21897658
http://dx.doi.org/10.4103/0975-1483.83758
work_keys_str_mv AT jagdalesc preparationandcharacterizationofmetforminhydrochloridecompritol888atosoliddispersion
AT patilsa preparationandcharacterizationofmetforminhydrochloridecompritol888atosoliddispersion
AT kuchekarbs preparationandcharacterizationofmetforminhydrochloridecompritol888atosoliddispersion
AT chabukswarar preparationandcharacterizationofmetforminhydrochloridecompritol888atosoliddispersion